IMVT vs MOS · $2.90B cap vs P/E 161, rev $11.12B
Immunovant Inc (IMVT) versus The Mosaic Company (MOS) — a side-by-side from cached financials, not a winner call.
Immunovant Inc (IMVT) is a biotechnology company listed on US.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
IMVT does not have a complete income-statement cache yet.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
IMVT currently screens at market cap $2.90B. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Not investment advice. Open the IMVT and MOS stock pages for the full models.
Not investment advice.